scholarly article | Q13442814 |
P356 | DOI | 10.3109/03009742.2010.548827 |
P698 | PubMed publication ID | 21453187 |
P50 | author | Katriina Vuolteenaho | Q41581634 |
Markku Kauppi | Q42340042 | ||
Lauri Lehtimäki | Q57295548 | ||
P2093 | author name string | E Moilanen | |
H Kautiainen | |||
O Ukkola | |||
M Hakala | |||
R Nieminen | |||
P Kontunen | |||
Ya Kesäniemi | |||
P2860 | cites work | Positional cloning of the mouse obese gene and its human homologue | Q22251285 |
Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1 | Q24816719 | ||
Inflammation and metabolic disorders | Q27860923 | ||
Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production | Q28115730 | ||
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. | Q33950766 | ||
Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans | Q34092732 | ||
Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. | Q34158851 | ||
Leptin in immunology | Q34400407 | ||
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Q34567335 | ||
The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes | Q34576388 | ||
The contribution of adipose tissue and adipokines to inflammation in joint diseases | Q34578951 | ||
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. | Q35135723 | ||
Leptin consumption in the inflamed joints of patients with rheumatoid arthritis | Q35552048 | ||
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. | Q35637875 | ||
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study | Q35638342 | ||
Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum | Q35760141 | ||
Molecular and anatomical determinants of central leptin resistance | Q36108714 | ||
Adipose tissue, adipokines, and inflammation | Q36114223 | ||
Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention | Q36171836 | ||
Intracellular signalling pathways activated by leptin | Q36334963 | ||
Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome | Q36419895 | ||
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications | Q36790316 | ||
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4 | Q37310966 | ||
Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis | Q37380362 | ||
Adiponectin, an unlocking adipocytokine | Q37389676 | ||
Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism | Q38303866 | ||
Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells | Q38357922 | ||
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects | Q39489191 | ||
Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica | Q42976143 | ||
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators | Q44263788 | ||
High expression of complement components in omental adipose tissue in obese men. | Q44477341 | ||
Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis | Q44613181 | ||
Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. | Q46568292 | ||
High prevalence of metabolic syndrome in patients with ankylosing spondylitis. | Q51491387 | ||
Plasma resistin levels correlate with determinants of the metabolic syndrome. | Q51922716 | ||
Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. | Q53584799 | ||
P433 | issue | 4 | |
P921 | main subject | metabolic syndrome | Q657193 |
P304 | page(s) | 256-262 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
P1476 | title | Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis | |
P478 | volume | 40 |
Q37700750 | Adipokines as potential biomarkers in rheumatoid arthritis |
Q26865268 | Adipokines, metabolic syndrome and rheumatic diseases |
Q33765673 | Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models |
Q50100973 | Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks |
Q60046584 | High plasma resistin associates with severe acute kidney injury in Puumala hantavirus infection |
Q50957777 | Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. |
Q47358338 | Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer |
Q47931115 | Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine |
Q39313031 | Resistin protects against 6-hydroxydopamine-induced cell death in dopaminergic-like MES23.5 cells |
Q92825085 | The Adipokine Network in Rheumatic Joint Diseases |
Q26785751 | The interplay between inflammation and metabolism in rheumatoid arthritis |
Search more.